Shanu Modi, MD
Breast Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
About Me
- Attending Physician
I am a medical oncologist with a clinical practice that is devoted solely to the care of patients with breast cancer.
My research activities are focused on the clinical development of new therapies for the treatment of breast cancer, with a particular emphasis on evaluating targeted biological anticancer agents. Currently, I am involved in phase I and phase II clinical trials to evaluate novel anti-HER2 therapies. Additional information about these clinical trials is available on Memorial Sloan Kettering’s website.
A breast medical oncologist is a cancer doctor who specializes in breast cancer.
My Specialties
- Breast Cancer
Education
- MD, University of Alberta
Residencies
- Internal Medicine - University of Alberta
- Medical Oncology - Cross Cancer Institute
Fellowships
- Breast Cancer Research - Memorial Sloan Kettering Cancer Center
Board Certifications
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Modi sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. I work closely with nurse practitioner Danielle Alleva. We combine our expertise to provide comprehensive care to our patients at every step of their cancer journey.
Clinical Trials
- Clinical Trials Investigated by Dr. Modi
- A Phase 1 Study of D3L-001 in People With Advanced Breast Cancer
- A Phase 1 Study of NUV-1511 in People With Advanced Breast Cancer
- A Phase 1b/2 Study of Disitamab Vedotin With Tucatinib in People With Solid Tumors
- A Phase I Study of DS-1062a in People with Advanced Digestive Cancers
Read more
- Clinical Trials Co-Investigated by Dr. Modi
- A Phase 1 Study of Valemetostat Tosylate in Combination With Dato-DXd in People With Lung Cancer and With T-DXd in People With Digestive Cancers
- A Phase I/IIA Study of DB-1303 in People with Advanced Endometrial Cancer or Endometrial Carcinosarcoma
- A Study of Trastuzumab Deruxtecan for People with Brain Cancer
- The STOP-HER2 Trial: A Phase 2 Study of Stopping Trastuzumab in People with Breast Cancer
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Modi’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Shanu Modi discloses the following relationships and financial interests:
-
AstraZeneca
Professional Services and Activities -
Daiichi Sankyo
Professional Services and Activities -
Genentech
Professional Services and Activities (Uncompensated)
-
Gilead Sciences, Inc.
Professional Services and Activities -
MacroGenics, Inc.
Professional Services and Activities (Uncompensated) -
Seagen
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].